Roger R. Dmochowski, MD

Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee

Dr. Roger R. Dmochowski is Professor at the Department of Urology and Vice Chair of the Department of Surgical Sciences at Vanderbilt University in Nashville. He is also Clinical Assistant Professor in Surgery at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. He is director of the pelvic reconstructive fellowship program at Vanderbilt. His administrative responsibilities include Executive Medical Director of Quality and Safety for Vanderbilt University Health System, Associate Chief of Staff Vanderbilt University Hospital, and Medical Director of Risk Management Vanderbilt University Medical Center. Dr. Dmochowski received his medical degree from the University of Texas Medical Branch at Galveston. He completed an internship and residency in surgery and urology at the University of Texas Medical School at Houston and at the M.D. Anderson Hospital and Tumor Institute in Texas. 

In addition, Dr. Dmochowski is subspecialty fellowship trained in female urology, neurourology, urodynamics and reconstructive urology – training which was completed at Kaiser Hospital Los Angeles. He is board certified in urology and female pelvic medicine and reconstructive surgery. 

Dr. Dmochowski has published more than 340 articles and book chapters, and 380 abstracts, and has given over 175 presentations at various national and international meetings. Dr. Dmochowski is on the editorial board for the World Journal of Urology, Neurourology and Urodynamics, and International Journal of Urogynecology, and he is a reviewer for the Journal of Urology, and Urology. He is a Fellow of the American College of Surgeons and a member of the American Urological Association and International Continence Society. Dr. Dmochowski has been granted the Zimskind Award from the Urodynamics Society for his accomplishment in clinical treatment for incontinence. 

His current research interests are outcomes of incontinence therapies with a particular emphasis on quality of life issues.